Abstract-We devised a new
Bronchi and bronchioles receive blood supply through the bronchial arteries. The bronchial circulation is therefore mainly responsible for maintaining functions of the airways.
An increase in respiratory resistance during bronchial asthma attack is ascribed to con strictions of bronchi and bronchioles, and hypersecretion of mucus evoked by asthma is also the result of responses of bronchi and bronchioles (that is, those of secretory glands and goblet cells). The anatomy of bronchial circulation, however, makes for limitations in physiological and pharmacological studies. Hitherto, hemodynamics of bronchial circu lation have been studied with the aortic sack method by Horisberger and Rodbard (1), and with the aortic tube method by DeKock et al. (2). These techniques are, however, rather complex and are necessarily accompanied by surgical trauma.
To our knowledge, asthmatic responses to antigen introduced into the bronchial arteries have not been reported; nor have the bronchosecretory activities of prostaglandins (PGs).
In the present study, we designed a new technique for allowing the direct application of drugs to the bronchial artery in the dog and for evaluating responses of bronchial muscula ture, vasculature and secretion, simultaneously with drug administrations. Table 1 . It was found that whole bronchi and bronchioles in the right lung and the right main bronchus were stained by the dye in most cases, while the left lung and alveoli in either lung were not substantially stained. Technique for measuring bronchomotor and bronchosecretory activities
The bronchomotor tone was measured by a modification of the Konzett-Rossler method (3). To assess bronchosecretory activity we combined the method with our technique (the stopper method described below). The cervical trachea was exposed by a midline incision, and the surrounding connective tissue was carefully dissected from the cartilage.
A midline incision was made at the 2nd to 8th cartilage rings beneath the cricoid cartilage and cauterization was used to minimize bleedings. A stopper, illustrated in 
Drugs and antigen
The drugs used were prostaglandins F2 a (Prostarnlon F, Ono; 1 mg/ml phosphate buffer), E2 (G512, Ono), histamine dihydrochloride (Wako Pure Chemicals) and isoproterenol hydrochloride (Sooner, Kaken Chemical). Solutions of PGE2 were prepared by dissolving the acid in phosphate buffer (pH 7.4) (1 mg/ml), kept frozen at --20°C, and the required volume was made up with 0.9% o NaCI solution at the time of experiment. PGF2a, histamine and isoproterenol were dissolved or diluted with 0.9 % NaCl solution. Doses of histamine and isoproterenol were expressed in terms of the salt.
Ascaris scum antigen was prepared following the method previously described (5).
Dogs naturally sensitive to ascaris antigen were selected by means of a skin test in which the animals that showed significant blueings at concentrations of below 10-6 g protein of the antigen solution were estimated to be positive. Ascaris antigen was injected or infused i.a. to dogs with a positive skin reaction.
RESULTS

Basal values of main parameters under resting conditions
With the dogs under pentobarbital anesthesia, the average normal perfused blood flow rate and tidal volume were 5.5+0.3 (S.E.M.) ml/min and 25 ' 1 cc/kg (N=49), respectively.
The corresponding values under anesthesia with a-chloralose were 4.5+0.7 mi/min and The systemic conditions including blood pressure and heart rate were more stable under the former anesthesia. Thus, all the experiments to be described were carried out in animals anesthetized with pentobarbital. The threshold dose of PGE2 for vasodilatation was much lower than that for bronchodilatation. The bronchoconstrictory activity of PGF2a seems to be lower than that of histamine, and the bronchodilatatory activity of PGE2 appears to be lower than that of isoproterenol. Infusions of PGE, at 0.1 to 1 ;ig/min i.a., produced decreases in overflow and perfusion pressure (Fig. 7) . Associated with this was a systemic hypotension.
The bronchodilatation induced by POE was maintained during infusion, and progressively recovered after cessation Of Infusion.
La. infusions of ascaris antigen at 0.1 to 0.3 mg protein/min to dogs with positive skin reaction to the antigen, gave a rise in overflow and a fall in perfusion pressure after a 1.5 4 min lag following the start of infusion (Fig. 8) . These responses lasted during infusion in most cases, and were, in some cases, followed by a systemic hypotension, probably due to systemic anaphylaxis.
Bronchosc ci'etoi'y responses to I.Q. drug infusions
The results obtained are summarized in Fig. 9 . The mean secretion volume for one hour after the start of i.a. infusion of saline was 0.032+0.010 ml (N=6).
Infusions of PGF2 in a dose range of 0.3-3 a-/min i.a. and those of ascaris antigen in doses of 0.1 and 0.3 mg protein/min caused a dose-dependent increase in airway secretion volume, whereas infusions of PGE, in a dose range of 0.1-1 ucg/min had no effect on the airway secretion.
There was no significant difference between the viscoelasticities of secretions collected after treatment with each drug. 
DISCUSSION
Perfusion of the cranial thyroid arteries for measuring responses of dog tracheal muscu lature and vasculature, in situ, has been reported (6), but using this method, actions of drugss on the bronchi and bronchioles cannot be determined since only a part of the upper treachea is perfused. As a technique for drug administration into the bronchial arteries, Horisberger and Rodhard (1) devised the aortic sack method which consists of isolation of the aortic pouch from which the major bronchial arteries originate and of drug administration into this pouch. The success ratio of operation is reportedly less than 50 percent as the animalss do not tolerate well this surgery (7). DeKock et al. (2) inserted an aortic tube into the thoracic aorta and this method has drawbacks in that the operation and apparatus are complex and exact responses of the bronchial arteries and airways to drugs are not procurable since the drug given passes through most intercostal arteries as well as the bronchial arteries.
Our present technique consists of a direct cannulation into the right bronchial artery and blood perfusion into the artery. The success ratio of surgery is substantially 100 percent.
The right bronchial artery in most cases arises from one branch of one of the right intercostal arteries. Cannulation into the right bronchial artery makes feasible the perfusion of the bronchi and bronchioles in the entire right lung without perfusing alveoli. In a preliminary experiment, an injection of dye solution into the pulmonary artery stained most of the alveoli of both lungs, but not the bronchi and bronchioles. Prominent responses of re spiratory tract could be observed when drugs were given into the cannulated right bronchial artery.
Using the present method, we assessed the bronchosecretory responses as well as re sponses of the bronchial vasculature and musculature, simultaneously. Among the methods for evaluating airway secretion in rivo, there is the direct method by Perry and Boyd (8), the dye leakage method by Sakuno (9), and the canine tracheal pouch method by Wardell et al. (10). Our stopper method is advantageous in that unlike the method of Perry and Boyd, measurement of secretory volume is not disturbed by evaporation or condensation of water in the tube through which humidified ventilatory air passes, and unlike the canine tracheal pouch method, the secretory activity throughout the airways, including bronchi and bronchioles, can be measured.
Using the aortic sack method (7) and the aortic tube method (2) the intrabronchial arterial injection of histamine induces a bronchoconstriction.
With our preparation, a clear bronchodilatation after an i.a. administration of isoproterenol as well as a bron choconstriction after histamine were observed. Thus our devised method makes feasible not only determination of bronchoconstricting responses but also bronchodilating ,ones.
Inhalation of ascaris suum antigen by dogs naturally sensitive to the antigen induces an asthmatic condition such as increases in respiratory resistance and secretion (5, 11). In the present study, it was confirmed that an i.a. administration of the antigen into the bron chial artery also induces a marked bronchoconstriction and an increase in bronchosecretory activity which are accompanied by a dilatation of the bronchial arterial bed. The bron chomotor response to an injection of the antigen, as compared with that to its infusion, was weak, or in some animals absent despite the appearance of systemic anaphylaxis, suggesting that in order to produce allergic reactions in the airways with an i.a. administration of the antigen, the tissues require sufficient exposure time to the antigen. The present study
indicates that an La. infusion of ascaris antigen into the bronchial artery provides a useful model for inducing bronchial asthma, at least in laboratory animals.
It has been proposed that a defect in metabolism of one or more of the PGs and the ratio of PGF2 Y to PGE9 may be an underlying cause of bronchial asthma (12, 13). This speculation stems from the following findings; relatively high concentrations of PGs were found in the lungs in several animal species including humans (14), and in the plasma of asthmatic patients (15). PGs are released from guinea pig lung during acute antigen antibody reactions (16), and are detectable in the perfusate of antigen-treated, IgE-sensitized human lung tissue (17). A systemic intravenous injection or inhalation of PGF2a is kno~sn to increase the bronchomotor tone, and PGE2 to decrease it in animals (18, 19), and humans ,(20 , 21). There is apparently no report that PGs have been given directly into the bronchial arteries. Influence of PGs on bronchial secretions has also not been documented. The bronchoconstrictory effect of PGF2 a and bronchodilatory effect of PGE2 were confirmed herein by La. injections into the bronchial artery, the doses producing active responses of either drug being over 0.1 ,ig. Pronounced bronchoconstrictory and bronchosecretory activities of PGF2 a were observed with i.a. infusion. Both the bronchomotor and secretory responses of PGF2 were similar to those seen in the cases of allergic reaction, while the vascular responses were opposite, that is, PGF2 « showed vasoconstriction while a vaso dilatation occurred with an allergic reaction. The doses of PGF2 used in this experiment were considerably high as compared with concentrations of PGF2 in the lungs and bronchi of both humans and animals. Such are reportedly 12-50 and 1.0-2.5 ng/g, respectively (14). Thus, PGF2a does not appear to be a chief mediator in asthma, though it is said (22) that effects of PGs may not depend upon the PGs stored in tissues, bur rather upon those produced in tissues when these tissues are stimulated by nerve excitation or some chemicals. The possibility that PGs may act as modulators of actions of other mediators such as histamine, is being investigated in our laboratory.
